SCHEMBL7774706

SCHEMBL7774706

C=COc1cccc(C)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
HTR1B P28222 1/20 0.43
KEAP1 Q14145 1/20 0.39
POLB P06746 1/20 0.39
TRPA1 O75762 1/20 0.38
ATM Q13315 1/20 0.38
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C19 P33261 2/20 0.36
DHFR P00374 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
LMNA P02545 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 2/20 0.34
NUDT1 P36639 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29591272 1.00 MAPT (0.46) MAPTHTR1BKEAP1POLBTRPA1
SCHEMBL194092 0.82 TSHR (0.43) MAPTKDM4EMEN1KMT2ACYP1A2
SCHEMBL5611771 0.81 SCN4A (0.33) MAPTMEN1KMT2ACYP1A2CYP3A4
SCHEMBL27804659 0.80 NCEH1 (0.31)
SCHEMBL13588219 0.79 CYP1A2 (0.52) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL9444806 0.79 ALDH1A1 (0.50) MAPTTRPA1ATMKDM4EGAA
SCHEMBL9444808 0.79 TRPA1 (0.45) MAPTTRPA1ATMKDM4EGAA
SCHEMBL13588215 0.79 CYP1A2 (0.38) MAPTHTR1BCYP1A2
Methyl Alcohol SCHEMBL4209931 0.78 TSHR (0.41) MAPTKDM4EMEN1KMT2ACYP1A2
SCHEMBL2095382 0.78 MAPT (0.50) MAPTHTR1BKEAP1POLBTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
US-20240402602-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-12-05 US disclosed
US-20240384056-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-11-21 US disclosed
US-12139567-B2 Curable composition, cured product, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-11-12 US disclosed
US-12129335-B2 Curable composition, cured product, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-10-29 US disclosed
US-20240239922-A1 PHOTOCURABLE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-07-18 US disclosed
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 US disclosed
US-20240191003-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 US disclosed
US-11981794-B2 Curable composition, cured product, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-05-14 US disclosed
CN-117999296-A Composition and photosensitive composition 东京应化工业株式会社 2024-05-07 CN disclosed
US-20180334533-A1 CURABLE COMPOSITION, CURED FILM, DISPLAY PANEL, AND METHOD FOR PRODUCING CURED PRODUCT TOKYO OHKA KOGYO CO., LTD (JP) 2018-11-22 US disclosed
US-20180251626-A1 CURABLE COMPOSITION, CURED PRODUCT OF THE CURABLE COMPOSITION, AND METHOD OF PRODUCING A CURED PRODUCT USING THE CURABLE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2018-09-06 US disclosed
US-9683150-B2 Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material TOKYO OHKA KOGYO CO., LTD. (JP) 2017-06-20 US disclosed
EP-2930200-B1 Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material TOKYO OHKA KOGYO CO LTD (JP) 2016-07-20 EP disclosed
EP-2930200-A1 Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material TOKYO OHKA KOGYO CO., LTD. (JP) 2015-10-14 EP disclosed
US-20150252229-A1 CURABLE COMPOSITION, ADHESIVE, METHOD OF PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL, AND FIBER-REINFORCED COMPOSITE MATERIAL TOKYO OHKA KOGYO CO., LTD. (JP) 2015-09-10 US disclosed
EP-0711813-B1 Antifouling coating composition HITACHI CHEMICAL CO LTD (JP) 2001-07-25 EP disclosed
US-5773508-A BIODEGRADABLE POLYMER OF ADDITION COPOLYMERS FOR PROTECTIVE COATINGS HITACHI CHEMICAL COMPANY, LTD. (JP) 1998-06-30 US disclosed
EP-0711813-A2 Coating varnish composition and antifouling coating composition Hitachi Chemical Co., Ltd. (JP) 1996-05-15 EP disclosed
US-5373032-A Hardness, flexible, wear and chemical resistant protective coatings ISP INVESTMENTS INC. (US) 1994-12-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12139567-B2 Curable composition, cured product, and compound CROCC, RCSD1, CRYZ MAPT 193/4885HTR1B 890/4885KEAP1 485/4885
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film C5, CFL1, C9 MAPT 3015/4885HTR1B 985/4885KEAP1 4686/4885
US-20240402602-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION CHMP4B, PHOSPHO1, EXOSC9 MAPT 506/4885HTR1B 1654/4885KEAP1 3197/4885
US-20240384056-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION CHMP4B, PHOSPHO1, EXOSC9 MAPT 527/4885HTR1B 1630/4885KEAP1 3227/4885
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION PPOX, ERCC1, ERCC5 MAPT 255/4885HTR1B 2305/4885KEAP1 795/4885
US-12129335-B2 Curable composition, cured product, and compound CROCC, RCSD1, WDR5 MAPT 280/4885HTR1B 749/4885KEAP1 1065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.